Table 1.
Sample ID | Major DR Mutation | Minor DR mutation |
AGDR4 | NONE | E138Q |
AGDR12 | NONE | K101Q |
AGDR35 | NONE | K103R |
AGDR37 | M184V, Y181C | NONE |
AGDR41 | NONE | A98G |
A98G is a minor mutation that reduces Nevirapine susceptibility by 2 to 3-fold. It is selected by Nucleoside Reverse Transcriptase Inhibitors (NRTIs) and Non-nucleoside Reverse Transcriptase Inhibitors (NNRTIs). K101Q is weakly associated with NNRTI therapy and minimally reduces susceptibility to each of the NNRTIs.
K103R occurs in about 1%–2% of untreated persons and by itself has no effect on NNRTI susceptibility.
E138Q is weakly associated with NNRTI therapy. It may contribute to decreased NNRTI susceptibility in certain genetic contexts.